Karyopharm Therapeutics, Inc. (KPTI)
6.31
-0.35
(-5.26%)
USD |
NASDAQ |
Jan 16, 16:00
6.25
-0.06
(-0.95%)
After-Hours: 20:00
Karyopharm Therapeutics Shareholders Equity (Annual): -186.02M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Bruker Corp. | 1.781B |
| IDEXX Laboratories, Inc. | 1.595B |
| TG Therapeutics, Inc. | 222.36M |
| Axsome Therapeutics, Inc. | 57.02M |
| Krystal Biotech, Inc. | 946.38M |